SciELO - Scientific Electronic Library Online

 
vol.59 número3Cribado de la actividad hipoglucémica in vitro de Murraya koenigii y Catharanthus roseuMétodos para medir la adherencia terapeútica índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Ars Pharmaceutica (Internet)

versão On-line ISSN 2340-9894

Resumo

DOMINGO-CHIVA, Esther et al. Multidisciplinary team of critically ill patient care: What is the contribution of the pharmacist?. Ars Pharm [online]. 2018, vol.59, n.3, pp.153-161. ISSN 2340-9894.  http://dx.doi.org/10.30827/ars.v59i3.7584.

Background and objective:

The severity and instability of the patients, together with the high degree of complexity of the medication, make the intensive care units (ICU) a critical area of problems related to medication. The aim of our study was to analyze and assess the activity performed by the clinical pharmacist integrated in an ICU and to know the opinion of the staff about it.

Material and method:

A 42 month descriptive and prospective study was conducted. The pharmacist was integrated into the daily activity of the multidisciplinary team of a 12-bed ICU belonging to the Anaesthesiology and Resuscitation Department. Every pharmacotherapeutic intervention (PI) carried out, the degree of acceptance, the method of communication and the receiver of the intervention, as well as the clinical evaluation of the accepted interventions were recorded. Subsequently, a survey was carried out to the staff of the unit on the patient´s safety and the influence of the integration of the pharmacist in the unit.

Results:

A total of 2399 PIs were carried out with a 97.0% of acceptance. Of these, most were those related to posology (37.8%) and consultations with the pharmacist (25.7%). Among the accepted PIs, 53.7% had an influence on the efficacy of drug therapy, and 35.1% on treatment tolerance. In the survey to the unit´s staff in order to assess the perception of the pharmacist´s integration, an overall assessment of 8.58 ± 1.40 out of 10 was obtained.

Conclusions:

The hospital pharmacist integrated in the ICU multidisciplinary team can add value to the pharmacotherapeutic process of the critical patient.

Palavras-chave : Pharmacists; intensive care units; patient care team; critical care; critical illness.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )